series-c-plus
Stage
1
Investors
About
VIVUS is a biopharmaceutical company that develops and commercializes therapies targeting serious medical conditions, with a focus on obesity and other therapeutic areas.
Explore VIVUS's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.